Details

Autor(en) / Beteiligte

• Costa, Thalita Cristina de Mello
• Chiari-Correia, Rodolfo
• Salmon, Carlos Ernesto G
• Darrigo-Junior, Luiz Guilherme
• Grecco, Carlos Eduardo S
• Pieroni, Fabiano
• Faria, Joana Teresa B
• Stracieri, Ana Beatriz P L
• Dias, Juliana B E
• de Moraes, Daniela Aparecida
• Oliveira, Maria Carolina
• Guerino-Cunha, Renato
• Santos, Antônio Carlos
• Simões, Belinda P

Titel

Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients

Ist Teil von

• Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2705-2713

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2021

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Brain injury in sickle cell disease (SCD) comprises a wide spectrum of neurological damage. Neurocognitive deficits have been described even without established neurological lesions. DTI is a rapid, noninvasive, and non-contrast method that enables detection of normal-appearing white matter lesions not detected by conventional magnetic resonance imaging (MRI). The aim of the study was to evaluate if stem cell transplantation can revert white matter lesions in patients with SCD. Twenty-eight SCD patients were evaluated with MRI and DTI before and after allogeneic hematopoietic stem cell transplantation (HSCT), compared with 26 healthy controls (HC). DTI metrics included fractional anisotropy (FA), mean diffusivity (MD), radial (RD), and axial (AD) diffusivity maps, global efficiency, path length, and clustering coefficients. Compared to HC, SCD patients had a lower FA (p = 0.0086) before HSCT. After HSCT, FA increased and was not different from healthy controls (p = 0.1769). Mean MD, RD, and AD decreased after HSCT (p = 0.0049; p = 0.0029; p = 0.0408, respectively). We confirm previous data of white matter lesions in SCD and present evidence that HSCT promotes recovery of brain injury with potential improvement of brain structural connectivity.